Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma
Taylor J Brueseke, Krishnansu S TewariDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California, Irvine, Orange, CA, USAAbstract: Ovarian cancer is the most deadly gynecologic cancer, with 15,000 anticipated deaths within the United States alone in 2012, and...
Guardado en:
Autores principales: | Brueseke TJ, Tewari KS |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bcfd5f4d05634caeb5e25b23ffa4b700 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Toll-like Receptors are Key Participants in Innate Immune Responses
por: ARANCIBIA,SERGIO A, et al.
Publicado: (2007) -
Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver.
por: Juandy Jo, et al.
Publicado: (2014) -
Impaired Innate Immunity in Pediatric Patients Type 1 Diabetes—Focus on Toll-like Receptors Expression
por: Katarzyna Kurianowicz, et al.
Publicado: (2021) -
Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer
por: Eskander RN, et al.
Publicado: (2013) -
Potential value of pharmacological agents acting on toll-like receptor (TLR) 7 and/or TLR8 in COVID-19
por: Amani E. Khalifa, PhD, et al.
Publicado: (2021)